Intelligence Platform
Patents
Browse 774 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 9592255
Scaffold-free three dimensional nerve fibroblast constructs
granted patentUS 9587071
Conjugated gold nanoparticles
granted patentUS 9580430
9H-pyrimido[4,5-B]indoles and related analogs as BET bromodomain inhibitors
granted patentUS 9568476
Diagnosis and treatment of breast cancer
granted patentUS 9566314
Extracellular vesicles comprising recombinant lysosomal transmembrane protein
granted patentUS 9555086
Compositions and methods for inducing an immune response
granted patentUS 9533045
Photothermal therapy using magnetic nanoparticles
granted patentUS 9527889
RFamide-related peptides and methods thereof
granted patentUS 9527878
Plasminogen activator inhibitor-1 inhibitors and methods of use thereof to modulate lipid
granted patentUS 9526786
Thermostabilization of proteins
granted patentUS 9517241
Amelioration of intestinal fibrosis and treatment of Crohn's disease
granted patentUS 9505782
Compositions comprising thienopyrimidine and thienopyridine compounds and methods of use t
granted patentUS 9505781
Compositions comprising thienopyrimidine and thienopyridine compounds and methods of use t
granted patentUS 9504688
Methods and compositions for treating bacterial infection
granted patentUS 9498571
Nitric oxide delivery devices
granted patentUS 9498566
Selective cytopheresis devices and related methods thereof
granted patentUS 9492538
Isolation and use of solid tumor stem cells
granted patentUS 9487579
Methods and compositions for modulation of blood-neural barrier
granted patentUS 9486422
Small molecule inhibitors of Mcl-1 and the uses of thereof
granted patentUS 9481717
Lectins and uses thereof
granted patentUS 9480785
Nitric oxide delivery devices
granted patentUS 9468632
Methods and compositions for targeting cancer stem cells
granted patentUS 9446107
Scaffolds for cell transplantation
granted patentUS 9446010
Compounds and methods for treating aberrant adrenocortical cell disorders
granted